As of December 2020, Saxenda is FDA-approved for use as a chronic weight management aid in adults and children over 12 years of age
Diwan Mayo Clinic, Rochester, MN Meeting: 2022 American Transplant Congress Abstract number: 790 Keywords: Kidney, Metabolic disease, Obesity Topic: Clinical Science Kidney 35 - Kidney: Cardiovascular and Metabolic Complications Session Information Session Name: Kidney: Cardiovascular and Metabolic Complications Session Type: Poster Abstract Date: Saturday, June 4, 2022 Session Time: 5:30pm-7:00pm Presentation Time: 5:30pm-7:00pm Location: Hynes Halls C & D *Purpose: Obesity is often a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes with many transplant centers setting BMI cut offs in order to be active on the waitlist
If you see something you'd like to flag with us or have additional questions, please don't hesitate to get in touchwe'd love to hear from you
Headaches are a less common but notable side effect
Recent significant clinical trials evaluating the efficacy of weight loss are summarized in Figure 5 and Figure 6
By Ziyad Al-Aly , Clinical Epidemiologist, Washington University in St
